Jackson Thornton Wealth Management’s AbbVie ABBV Stock Holding History

Jackson Thornton Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$472K	Buy	+1,874	New	+$403K	0.04%	164
2026 Q1	–	Sell	-1,776	Closed	-$398K	–	287
2025 Q4	$398K	Buy	1,776 +297	+20%	+$67.7K	0.04%	143
2025 Q3	$342K	Buy	1,479 +24	+2%	+$4.89K	0.03%	159
2025 Q2	$276K	Buy	1,455 +82	+6%	+$15.2K	0.03%	92
2025 Q1	$238K	Buy	1,373 +173	+14%	+$33.6K	0.03%	80
2024 Q4	$213K	Buy	1,200 +2	+0.2%	+$368	0.03%	78
2024 Q3	$237K	Sell	1,198 -4	-0.3%	-$747	0.03%	56
2024 Q2	$206K	Sell	1,202 -29	-2%	-$4.8K	0.03%	53
2024 Q1	$224K	Buy	+1,231	New	+$212K	0.04%	48
2022 Q3	–	Sell	-1,446	Closed	-$221K	–	30
2022 Q2	$221K	Buy	1,446 +192	+15%	+$29.3K	0.06%	24
2022 Q1	$203K	Buy	+1,254	New	+$182K	0.05%	25

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jackson Thornton Wealth Management's ABBV Position: Q2 2026 in Review

Jackson Thornton Wealth Management opened a new position in AbbVie (ABBV) in Q2 2026: 1,874 shares worth $472K. The stake represents 0.04% of the portfolio and ranks #164 among its holdings. This is a return to the name: Jackson Thornton Wealth Management previously reported a position in ABBV as recently as Q4 2025.

Jackson Thornton Wealth Management first reported a position in ABBV in Q1 2022 and has held it in 11 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Jackson Thornton Wealth Management held 1,874 shares of AbbVie worth $472K as of Q2 2026.
AbbVie was a new Jackson Thornton Wealth Management position in Q2 2026.
AbbVie made up 0.04% of Jackson Thornton Wealth Management's portfolio in Q2 2026, its #164 holding.
Jackson Thornton Wealth Management first reported a position in AbbVie in Q1 2022 and has held it in 11 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Jackson Thornton Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.